1. Home
  2. EDBL vs VTAK Comparison

EDBL vs VTAK Comparison

Compare EDBL & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Edible Garden AG Incorporated

EDBL

Edible Garden AG Incorporated

HOLD

Current Price

$1.21

Market Cap

4.0M

ML Signal

HOLD

Logo Catheter Precision Inc.

VTAK

Catheter Precision Inc.

N/A

Current Price

$2.16

Market Cap

4.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EDBL
VTAK
Founded
2020
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0M
4.1M
IPO Year
2022
2018

Fundamental Metrics

Financial Performance
Metric
EDBL
VTAK
Price
$1.21
$2.16
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
66.7K
30.0K
Earning Date
11-14-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$12,553,000.00
$730,000.00
Revenue This Year
$29.56
$822.86
Revenue Next Year
$20.00
$168.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
82.96
52 Week Low
$1.05
$1.49
52 Week High
$13.50
$15.68

Technical Indicators

Market Signals
Indicator
EDBL
VTAK
Relative Strength Index (RSI) 43.23 50.29
Support Level $1.05 $1.50
Resistance Level $1.25 $2.19
Average True Range (ATR) 0.12 0.17
MACD 0.01 0.03
Stochastic Oscillator 60.00 70.26

Price Performance

Historical Comparison
EDBL
VTAK

About EDBL Edible Garden AG Incorporated

Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

Share on Social Networks: